Cambridge Trust’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $12.9K | Hold |
5,000
| – | – | ﹤0.01% | 560 |
|
|
2023
Q4 | $12.5K | Hold |
5,000
| – | – | ﹤0.01% | 557 |
|
|
2023
Q3 | $10.2K | Hold |
5,000
| – | – | ﹤0.01% | 579 |
|
|
2023
Q2 | $11.5K | Hold |
5,000
| – | – | ﹤0.01% | 586 |
|
|
2023
Q1 | $15.2K | Hold |
5,000
| – | – | ﹤0.01% | 587 |
|
|
2022
Q4 | $12K | Hold |
5,000
| – | – | ﹤0.01% | 609 |
|
|
2022
Q3 | $10K | Hold |
5,000
| – | – | ﹤0.01% | 639 |
|
|
2022
Q2 | $14K | Hold |
5,000
| – | – | ﹤0.01% | 637 |
|
|
2022
Q1 | $15K | Hold |
5,000
| – | – | ﹤0.01% | 697 |
|
|
2021
Q4 | $19K | Buy |
+5,000
| New | +$19K | ﹤0.01% | 697 |
|